Literature DB >> 24637419

Prostate cancer: substratification of intermediate-risk disease using the current NCCN criteria.

David Killock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24637419     DOI： 10.1038/nrurol.2014.66

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Stratification of patients with intermediate-risk prostate cancer.

Authors:  Jin-Woo Jung; Jung Keun Lee; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee
Journal:  BJU Int       Date:  2015-03-27       Impact factor: 5.588
  1 in total
  1 in total

1.  Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer.

Authors:  Ho Won Kang; Hae Do Jung; Joo Yong Lee; Jong Kyou Kwon; Seong Uk Jeh; Kang Su Cho; Won Sik Ham; Young Deuk Choi
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.